Results 41 to 50 of about 1,185 (135)

Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001-2011). [PDF]

open access: yesBMJ Open, 2013
ObjectiveTo determine the extent of substandard and falsified medicines in the UK.DesignA retrospective review of drug alerts and company-led recalls.SettingThe Medicines and Healthcare Products Regulatory Agency (MHRA) website search for drug alerts issued between 2001 and 2011.Eligibility criteriaDrug alerts related to quality defect in medicinal ...
Almuzaini T, Sammons H, Choonara I.
europepmc   +5 more sources

Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review

open access: yesJournal of Pharmaceutical Policy and Practice
Background: Substandard, falsified, unlicensed, and unregistered medicines pose significant risks to public health in developed and developing countries. This systematic review provides an overview of the prevalence of substandard, falsified, unlicensed,
Biset Asrade Mekonnen   +2 more
doaj   +1 more source

Quality of medicines in southern Togo: Investigation of antibiotics and of medicines for non-communicable diseases from pharmacies and informal vendors.

open access: yesPLoS ONE, 2018
Substandard and falsified medicines represent a serious threat for public health and patient safety. Especially in low and middle-income countries, the prevalence of substandard and falsified medicines is reportedly high. However, reliable information on
Simon Schäfermann   +3 more
doaj   +1 more source

Technologies for detecting falsified and substandard drugs in low and middle-income countries. [PDF]

open access: yesPLoS ONE, 2014
Falsified and substandard drugs are a global health problem, particularly in low- and middle-income countries (LMIC) that have weak pharmacovigilance and drug regulatory systems.
Stephanie Kovacs   +5 more
doaj   +1 more source

Advancing health system strengthening through improving access to medicines: A review of local manufacturing policies in Ghana

open access: yesMedicine Access @ Point of Care, 2020
Providing access to quality-assured medicines is a fundamental component of strengthening health systems. Yet, the World Health Organization (WHO) estimates that 13.6% of all medicines in low- and middle-income countries (LMIC’s) may be substandard or ...
Kwame Peprah Boaitey, Chloe Tuck
doaj   +1 more source

Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model

open access: yesBMC Public Health, 2020
Background Many countries are striving to become malaria-free, but global reduction in case estimates has stagnated in recent years. Substandard and falsified medicines may contribute to this lack of progress. Zambia aims to eliminate their annual burden
Kathryn D. Jackson   +7 more
doaj   +1 more source

Hidden Costs of Ethical Fashion: Sustainable Development Goals and Garment Worker Exploitation in Bangladesh

open access: yesSustainable Development, EarlyView.
ABSTRACT Across garment factories in the Global South, the promise of “ethical fashion” coexists with poverty wages and retaliation. This study examines why the global call for decent work has not improved labor conditions in Bangladesh's ready‐made garment industry.
Md. Rafiqul Islam Rana
wiley   +1 more source

Consigning Injustice to History with Political Apologies

open access: yesJournal of Applied Philosophy, EarlyView.
ABSTRACT Failures to remember the past properly can constitute a range of different wrongs. In this article, we identify a novel kind of wrong that often occurs through political apologies: consigning an injustice to history. Consigning acknowledges that a historical injustice took place but denies that it has any ongoing relevance for the present ...
Alfred Archer, Benjamin Matheson
wiley   +1 more source

Medicine quality assessment in Nepal using semi randomised sampling and evaluation of a small scale dissolution test and portable Raman spectrometers

open access: yesScientific Reports
Substandard and falsified medicines threaten global health and require reliable data and screening technologies to combat their spread. This study examined the quality of 241 samples containing azithromycin, cefixime, esomeprazole and losartan collected ...
Robin Schreiber   +6 more
doaj   +1 more source

The Role of Pharmacists in Tackling Mpox: Challenges and Future Prospects: A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims Pharmacists play a key role in managing and mitigating mpox through clinical care, pharmacovigilance, vaccine management, and resilient supply chains. Management focuses on supportive care, infection prevention, and accurate diagnosis, with pharmacists ensuring the availability and rational use of vaccines, disinfectants ...
Ayalew Sirbemo Degebo   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy